Insights On CONTRACT PHARMA MANUFACTURING

  1. Revolutionizing The Development, Characterization, And Manufacturing Of Peptides 7/24/2026

    Erik Feldmann, Technical Director, on the analytical challenges of proteins, peptides, and oligonucleotides — and why he starts every method-development problem by understanding what the customer is trying to achieve.

  2. Approaching DoE During Process Characterization 7/24/2026

    Insights into the validation expertise behind process characterization and how deep problem-solving can turn a process into one robust enough to carry a drug to market.

  3. Cross-Site Work Within Cambrex's Network 7/24/2026

    Matthew Zart, Group Leader of Analytical Development, on what happens when a method arrives from another site — inheriting Phase II work from High Point and getting it commercial-ready for the QC lab.

  4. Keeping Future Manufacturing Options Open During Development 7/24/2026

    Early choices affect manufacturing flexibility, tech transfer, and supply chain resilience. Addressing IP and production needs early helps preserve options for commercialization.

  5. Emerging Technologies In Reactor Design 7/23/2026

    Jillian Sheeran, Associate Director of Engineering at Snapdragon Chemistry, on how automation, feedback control, and machine learning are changing reactor design — with real-time monitoring that lets a process run continuously while the data comes to you.

  6. How Solid-State Characterization Shapes Drug Development 7/23/2026

    Mark Benger, Site Director at Cambrex Edinburgh, on solid-state characterization as an insurance policy — front-loaded work that quietly determines whether a program survives the jump from kilos to tonnes.

  7. How Biocatalysts Address Process Development Issues 7/23/2026

    Antje Gupta, General Manager of Cambrex IEP in Wiesbaden, on where biocatalysis outperforms conventional chemistry — matching enzyme classes to target conversions and production volumes to find the more scalable, more economical route.

  8. How Do You Start Process Transfer For A New Client? 7/23/2026

    Anmaris Torres, Process Engineering Team Leader, on why a process transfer starts with a conversation across departments to figure out how to cut cycle time before commercial production begins.

  9. How Does Cambrex Approach Peptide Development? 7/23/2026

    Adrian Amador, Director of Chemistry at Snapdragon Chemistry, on rethinking peptide development from the ground up and how liquid-phase processes are delivering efficiency gains.

  10. Optimizing Yield, Purity, And Scalability In A Cost-Effective Manner During Process Development 7/23/2026

    Daniele Vigo, Assistant Director at Cambrex Milan, on getting yield, purity, and scalability right without burning through the budget.